Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ImmunoGen, OBT partner to develop new antibody-drug conjugates for cancers
ImmunoGen and Oxford BioTherapeutics will use their respective technologies to develop new antibody-drug conjugates. Credit: National Cancer Institute on Unsplash.
ImmunoGen and Oxford BioTherapeutics will use their respective technologies to develop new antibody-drug conjugates. Credit: National Cancer Institute on Unsplash.